21Apr 2025
Immune-Related Adverse Events Linked to Better Outcomes in Advanced Melanoma, but Steroid Timing and Dosage Matter

Immune-Related Adverse Events Linked to Better Outcomes in Advanced Melanoma, but Steroid Timing and Dosage Matter

A multicenter study found that immune-related adverse events (irAEs) in advanced melanoma patients treated with ICIs are associated with improved survival. However, early and high-dose corticosteroid use may negatively impact outcomes, underscoring the importance of tailored immunosuppression strategies.

  • #oncology
  • #dermatology

Like

Save

Share